Cian Healthcare received BSE trading approval on March 30, 2026 for 2,50,00,000 equity shares (face value ₹10 each) under an NCLT-approved Resolution Plan.
Of the total shares, 12,50,000 were allotted to public shareholders and 2,37,50,000 to promoters, per the Resolution Plan of SRA Mr. Pradeep Kumar Jain.
Trading in these shares is effective from April 02, 2026, with distinctive numbers ranging from 1 to 25,000,000 on BSE Limited.